AG

Artal Group Portfolio holdings

AUM $930M
1-Year Est. Return 3.57%
This Quarter Est. Return
1 Year Est. Return
-3.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.12B
AUM Growth
+$1.44B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
139
New
Increased
Reduced
Closed

Top Buys

1
+$1.31B
2
+$63.6M
3
+$38.1M
4
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$20.4M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$18.7M

Top Sells

1
+$61.1M
2
+$15.8M
3
+$15.1M
4
FATE icon
Fate Therapeutics
FATE
+$14.8M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$13.1M

Sector Composition

1 Healthcare 56.49%
2 Consumer Discretionary 42.78%
3 Technology 0.24%
4 Financials 0.2%
5 Real Estate 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
126
– –
-511,389
127
– –
-750,000
128
– –
-511,784
129
– –
-300,000
130
– –
-14,818,300
131
– –
0
132
– –
-1,747
133
– –
-258,687
134
– –
-4,318
135
– –
-121,756
136
– –
-750,000
137
– –
-2,042,666
138
– –
-924,898
139
– –
-18,750
2 3 4 5
6